Waters Corporation
its BioResolve Peptide and GTxResolve Lipid columns (230 Å) deliver up to 3x faster GLP-1 characterization and 2x faster LNP analysis, with a global launch from June 2026.
- Country
- United States
- Ticker
- NYSE: WAT
ISO 9001
Coverage
| CN | EU | US | |
|---|---|---|---|
| analytics-pat | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioprocess analytics & PAT (process analytical technology) | analytics-pat | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.